These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

850 related articles for article (PubMed ID: 33585529)

  • 1. Effect of Convalescent Plasma in Critically Ill Patients With COVID-19: An Observational Study.
    Kurtz P; Righy C; Gadelha M; Bozza FA; Bozza PT; Gonçalves B; Bastos LSL; Vale AM; Higa LM; Castilho L; Monteiro FL; Charris N; Fialho F; Turon R; Guterres A; Lyra Miranda R; de Azeredo Lima CH; de Caro V; Prazeres MA; Ventura N; Gaspari C; Miranda F; Jose da Mata P; Pêcego M; Mateos S; Lopes ME; Castilho S; Oliveira Á; Boquimpani C; Rabello A; Lopes J; Neto OC; Ferreira ODC; Tanuri A; Filho PN; Amorim L
    Front Med (Lausanne); 2021; 8():630982. PubMed ID: 33585529
    [No Abstract]   [Full Text] [Related]  

  • 2. Convalescent Plasma Efficacy in Life-Threatening COVID-19 Patients Admitted to the ICU: A Retrospective Cohort Study.
    Abuzakouk M; Saleh K; Algora M; Nusair A; Alameri J; Alshehhi F; Alkhaja S; Badr M; Abdallah K; De Oliveira B; Nadeem A; Varghese Y; Munde D; Salam S; Abduljawad B; Elkambergy H; Wahla A; Taha A; Dibu J; Bayrlee A; Hamed F; AbdelWareth L; Rahman N; Guzman J; Mallat J
    J Clin Med; 2021 May; 10(10):. PubMed ID: 34068847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial.
    Sekine L; Arns B; Fabro BR; Cipolatt MM; Machado RRG; Durigon EL; Parolo E; Pellegrini JAS; Viana MV; Schwarz P; Lisboa TC; Dora JMS; Portich JP; Paz AA; Silla L; Balsan AM; Schirmer FD; Franz JPM; da-Silveira LM; Breunig RC; Petersen V; Sosnoski M; Mesquita NF; Volpato FCZ; Sganzerla D; Falavigna M; Rosa RG; Zavascki AP;
    Eur Respir J; 2022 Feb; 59(2):. PubMed ID: 34244316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convalescent Plasma Therapy in Critically Ill COVID-19 Patients: An Open Label Trial.
    Khamis F; Al Arimi Z; Al Naamani H; Al Bahrani M; Pandak N; Al Bolushi Z; Deenadayalan SS; Al Lawati A; Al Salmi I; Al-Zakwani I
    Oman Med J; 2021 Sep; 36(5):e296. PubMed ID: 34631155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Convalescent Plasma in the Management of Critically Ill COVID-19 Patients (with No Detectable Neutralizing Antibodies Nab) in Kashmir, India.
    Elkhalifa AME; Nabi SU; Shah NN; Dar KA; Quibtiya S; Bashir SM; Ali SI; Taifa S; Hussain I
    Healthcare (Basel); 2023 Jan; 11(3):. PubMed ID: 36766892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic plasma exchange followed by convalescent plasma transfusion in severe and critically ill COVID-19 patients: A single centre non-randomized controlled trial.
    Novacescu AN; Duma G; Buzzi B; Baditoiu LM; Bedreag O; Papurica M; Sandesc D; Sorescu T; Vlad D; Licker M
    Exp Ther Med; 2022 Jan; 23(1):76. PubMed ID: 34934447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational study.
    Hatzl S; Posch F; Sareban N; Stradner M; Rosskopf K; Reisinger AC; Eller P; Schörghuber M; Toller W; Sloup Z; Prüller F; Gütl K; Pilz S; Rosenkranz AR; Greinix HT; Krause R; Schlenke P; Schilcher G
    Ann Intensive Care; 2021 May; 11(1):73. PubMed ID: 33978844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The modified NUTRIC score can be used for nutritional risk assessment as well as prognosis prediction in critically ill COVID-19 patients.
    Zhang P; He Z; Yu G; Peng D; Feng Y; Ling J; Wang Y; Li S; Bian Y
    Clin Nutr; 2021 Feb; 40(2):534-541. PubMed ID: 32527576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis.
    Pappa V; Bouchla A; Terpos E; Thomopoulos TP; Rosati M; Stellas D; Antoniadou A; Mentis A; Papageorgiou SG; Politou M; Kotanidou A; Kalomenidis I; Poulakou G; Jahaj E; Korompoki E; Grigoropoulou S; Hu X; Bear J; Karaliota S; Burns R; Pagoni M; Trontzas I; Grouzi E; Labropoulou S; Stamoulis K; Bamias A; Tsiodras S; Felber BK; Pavlakis GN; Dimopoulos MA
    Microorganisms; 2021 Apr; 9(4):. PubMed ID: 33920489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convalescent Plasma for COVID-19: A Single Center Prospective Experience with Serial Antibody Measurements and Review of the Literature.
    Whang SN; Shah VD; Pu L; Sheth P; Lucas GN; Lee J; Lee M; Lacy C; Duerksen-Hughes PJ; Filippov V; Lee DJH; Veltman J; Maken K; Reeves ME; Stevens WT; Herrmann P; Cao H; Lau E
    Pathogens; 2022 Aug; 11(9):. PubMed ID: 36145390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical Illness Due to Covid-19: A Description of the Surge in a Single Center in Sioux Falls.
    Jamous F; Meyer N; Buus D; Ateeli H; Taggart K; Hanson T; Alzoubaidi M; Nazir J; Devasahayam J
    S D Med; 2020 Jul; 73(7):312-317. PubMed ID: 32805781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Convalescent Plasma Therapy for COVID-19 Patients in Hunan, China.
    Hu X; Hu C; Jiang D; Zuo Q; Li Y; Wang Y; Chen X
    Dose Response; 2020; 18(4):1559325820979921. PubMed ID: 33402882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of convalescent plasma therapy in eight individuals with mild COVID-19.
    Ji F; Liu W; Hao DA; Cheng J; Tong XC; Hao JG; Wang LP; Li CY; Dai MJ; Yan XB
    New Microbes New Infect; 2021 Jan; 39():100814. PubMed ID: 33204428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and outcomes of critically ill COVID-19 patients in Tokyo: a single-center observational study from the first wave.
    Banno A; Hifumi T; Okamoto H; Masaki M; Seki K; Isokawa S; Otani N; Hayashi K; Ishimatsu S
    BMC Infect Dis; 2021 Feb; 21(1):163. PubMed ID: 33563218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients.
    Jonmarker S; Hollenberg J; Dahlberg M; Stackelberg O; Litorell J; Everhov ÅH; Järnbert-Pettersson H; Söderberg M; Grip J; Schandl A; Günther M; Cronhjort M
    Crit Care; 2020 Nov; 24(1):653. PubMed ID: 33225952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of COVID-19: Perspective on Convalescent Plasma Transfusion.
    Farhat RM; Mousa MA; Daas EJ; Glassberg MK
    Front Med (Lausanne); 2020; 7():435. PubMed ID: 32850916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convalescent Plasma Therapy in Four Critically Ill Pediatric Patients With Coronavirus Disease 2019: A Case Series.
    Schwartz SP; Thompson P; Smith M; Lercher DM; Rimland CA; Bartelt L; Park YA; Weiss S; Markmann AJ; Raut R; Premkumar L; Kuruc J; Willis Z
    Crit Care Explor; 2020 Oct; 2(10):e0237. PubMed ID: 33063037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
    Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
    Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates.
    Verma HK; Farran B; Bhaskar LVKS
    Antib Ther; 2020 Apr; 3(2):115-125. PubMed ID: 33912791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Exchange in Patients With Severe Coronavirus Disease 2019: A Single-Center Experience.
    Nusshag C; Morath C; Speer C; Kaelble F; Zeier M; Boxberger M; Schulze-Schleithoff E; Fiedler MO; Weigand MA; Merle U
    Crit Care Explor; 2021 Aug; 3(8):e0517. PubMed ID: 34476404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.